Ibezapolstat for C. difficile Infection
What You Need to Know Before You Apply
What is the purpose of this trial?
Single-arm trial to evaluate the safety and efficacy of ACX-362E \[ibezapolstat\] in patients with recurrent C. difficile infection (CDI).
Are You a Good Fit for This Trial?
This trial is for people who have had at least three episodes of C. difficile infection in the past year, including their current episode, with diarrhea and a positive stool test. At least one previous episode must have been treated with vancomycin or fidaxomicin.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Ibezapolstat
Trial Overview
The study tests ibezapolstat (ACX-362E), an oral antibiotic, to see if it is safe and effective for treating people with recurrent C. difficile infections. All participants receive this medication; there is no comparison group.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Active investigational antibacterial agent
Find a Clinic Near You
Who Is Running the Clinical Trial?
Acurx Pharmaceuticals Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.